Stromal Immunology
@stromal_immunol
Stromal Immunology news & views from across the world. Anne Fletcher tweeting / retweeting.
ID: 991151710507646976
01-05-2018 03:05:57
3,3K Tweet
1,1K Followers
595 Following
Time is running out for you to join the next big conversation in #stromal immunology 📅 #KSStromal26 is coming to you at Fairmont Banff Springs. Don’t miss the chance to learn, connect with field leaders, and ski in the mountains. 🏔️ Short talks abstract close on October 7th.
Early-career scientists, don’t miss out! ⏰ Submit your short talk abstract or scholarship app for the Fibrosis meeting by Oct 7 (11:59pm MDT). Join Dr. Thomas Wynn (Pfizer Inc.) in Banff 🔗 keysym.us/KSFibrosis26 🎥 youtu.be/ayWm6vA3hIw Florian Rieder Marco Prunotto #KSFibrosis26
🚨 SHORT TALK SUBMISSION ENDS SOON 🚨 Don't miss out on your chance to be apart of the biggest stromal conversation at #KSStromal26. Held at the beautiful Fairmont Banff Springs. There will be lots of skiing, snow and all things stromal 🏔️ Register now: keysym.us/KSStromal26
We are pleased to host Ruth Shouval at #KSStromal26. Her team studies how tumours reprogram the local microenvironment to enable systematic malignancies. One of the way tumours predominantly do this is by interacting with #fibroblast. Register now - keysym.us/KSStromal26🏔️
📢 Call for paper submissions in npj Journals npj Biological Physics & Mechanics special collection on: Mechanobiology of the Extracellular Matrix! 📅 Deadline: 14 May 2026 🔗 nature.com/collections/ba… More info👇(1/7) #ExtracellularMatrix #ECM #Mechanobiology #natureportfolio
🚀 Don’t miss michael briskin, CSO & founding member of Phenomic AI, as he shares how machine learning–powered transcriptomics is driving new drug target discovery in the tumour microenvironment. Register by 22nd October. keysym.us/KSStromal26 #KSStromal26
Discover how stromal cells contribute to therapy resistance in cancer with Fatima Mechta-Grigoriou, an internationally recognised leader in tumour heterogeneity. At #KSStromal26, she will share her insights on CAF-driven immunosuppression in breast cancer. keysym.us/KSStromal26